Neusignal Therapeuticsは、アルツハイマー型認知症（AD）治療候補化合物NTX-083の開発に取り組んでいます。
Investors 1
| Date | Name | Website |
| - | Fast Track... | us.fasttra... |
Mentions in press and media 3
| Date | Title | Description |
| 03.03.2024 | Neusignal Therapeutics Co., Ltd. Neusignal Therapeutics raised SeedRound approximately 1.33 billion yen from a total of 5 companies including Fast Track Initiative Co., Ltd. and Keio Innovation Initia... | Neusignal Therapeutics Co., Ltd. Neusignal Therapeutics raises SeedRound approximately 1.33 billion yen from 5 companies including Fast Track Initiative Co., Ltd. and Keio Innovation Initiative Co., Ltd. and AMED subsidy Accelerating clinic... |
| 03.03.2024 | Neusignal Therapeutics Co., Ltd. Neusignal Therapeutics raised SeedRound approximately 1.33 billion yen from a total of 5 companies including Fast Track Initiative Co., Ltd. and Keio Innovation Initia... | - |
| - | Neusignal Therapeutics | “Neusignal Therapeutics ” |